QPS
Groningen, Hanzeplein 1, 9713 GZ, Netherlands
NCT Number: NCT01734590
Exploratory study with double-blind, randomized, placebo-controlled, full cross-over design.
The main objective is to identify one or two flour compositions in a carbohydrate-based food that produce a significant difference (alpha =0.2) in the time to reach 50% of cumulative absorption of exogenous glucose compared to the control.
Looking for future studies?
Notify Me18 year–50 year
Male
Interventional
Not applicable
Groningen, Hanzeplein 1, 9713 GZ, Netherlands
Twelve volunteers will participate in the study; each person will be studied on three different occasions at least one week apart, consuming the three different test products in a randomized order. Test products are carbohydrate-based food made from different flour mixes differing in their expected rate of intestinal starch digestion. The products are labeled with 13C starch.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Carbohydrate based food
Other names: Slowly digestible carbohydrate
Carbohydrate based food
Other names: Slowly digestible carbohydrate
Carbohydrate based food
Other names: Rapidly digestible carbohydrate
Time frame: Measured during 360 min for 3 periods
Time frame: Measured during 360 min for 3 periods
Unilever R&D
Industry
The Effect of Different Flour Compositions in a Carbohydrate-based Food on Rate of Exogenous Glucose Appearance in Blood.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details